Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1951 2
1952 2
1953 3
1954 1
1955 5
1956 8
1957 13
1958 11
1959 32
1960 47
1961 48
1962 49
1963 41
1964 61
1965 50
1966 37
1967 34
1968 34
1969 69
1970 60
1971 45
1972 78
1973 164
1974 193
1975 187
1976 194
1977 185
1978 146
1979 181
1980 147
1981 135
1982 241
1983 221
1984 287
1985 235
1986 197
1987 223
1988 205
1989 194
1990 243
1991 188
1992 255
1993 259
1994 270
1995 326
1996 325
1997 292
1998 321
1999 370
2000 432
2001 387
2002 390
2003 463
2004 477
2005 518
2006 613
2007 613
2008 668
2009 723
2010 708
2011 855
2012 827
2013 869
2014 905
2015 946
2016 969
2017 951
2018 977
2019 964
2020 1108
2021 1127
2022 1119
2023 927
2024 974
2025 1093
2026 87

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,772 results

Results by year

Filters applied: . Clear all
Page 1
Research progress on live attenuated vaccine against African swine fever virus.
Liu L, Wang X, Mao R, Zhou Y, Yin J, Sun Y, Yin X. Liu L, et al. Microb Pathog. 2021 Sep;158:105024. doi: 10.1016/j.micpath.2021.105024. Epub 2021 Jun 3. Microb Pathog. 2021. PMID: 34089790 Free article. Review.
ASFV has a large genome and complex immune escape mechanism creating difficulties in the production of vaccines. Recently, remarkable advances have been made in vaccine development all over the world especially in live-attenuated vaccine. This a …
ASFV has a large genome and complex immune escape mechanism creating difficulties in the production of vaccines. Recently, remarkable …
Live Attenuated Influenza Vaccine: Is Past Performance a Guarantee of Future Results?
Jhaveri R. Jhaveri R. Clin Ther. 2018 Aug;40(8):1246-1254. doi: 10.1016/j.clinthera.2018.07.003. Epub 2018 Aug 6. Clin Ther. 2018. PMID: 30093132 Review.
Live attenuated influenza vaccine (LAIV) has had a tumultuous recent history that can be difficult for many to follow and understand. ...
Live attenuated influenza vaccine (LAIV) has had a tumultuous recent history that can be difficult for many to follow a …
Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasis.
Pandey SC, Kumar A, Samant M. Pandey SC, et al. Parasite Immunol. 2020 Sep;42(9):e12732. doi: 10.1111/pim.12732. Epub 2020 May 28. Parasite Immunol. 2020. PMID: 32418227 Review.
There is now a broad consent among Leishmania researchers that the perseverance of parasite is very essential for eliciting a protective immune response and may perhaps be attained by live attenuated parasite vaccination. For making a live attenuated p …
There is now a broad consent among Leishmania researchers that the perseverance of parasite is very essential for eliciting a protective imm …
Prospects on Repurposing a Live Attenuated Vaccine for the Control of Unrelated Infections.
Seo SU, Seong BL. Seo SU, et al. Front Immunol. 2022 May 16;13:877845. doi: 10.3389/fimmu.2022.877845. eCollection 2022. Front Immunol. 2022. PMID: 35651619 Free PMC article. Review.
Live vaccines use attenuated microbes to acquire immunity against pathogens in a safe way. As live attenuated vaccines (LAVs) still maintain infectivity, the vaccination stimulates diverse immune responses by mimicking natural infection. …
Live vaccines use attenuated microbes to acquire immunity against pathogens in a safe way. As live attenuated …
Live attenuated vaccine vectors.
Mekalanos JJ. Mekalanos JJ. Int J Technol Assess Health Care. 1994 Winter;10(1):131-42. doi: 10.1017/s0266462300014057. Int J Technol Assess Health Care. 1994. PMID: 8157445 Review.
Several different live attenuated vaccine vectors currently are under development. These vaccines are composed of living viruses or bacteria that are innocuous to the host but can replicate in host tissues and induce immune responses. The genes encodin …
Several different live attenuated vaccine vectors currently are under development. These vaccines are composed o …
Live-attenuated vaccine failure after liver transplantation: A 20-year cohort study.
Furuichi M, Ohnishi T, Yaginuma M, Yamada Y, Hoshino K, Nakayama T, Shinjoh M. Furuichi M, et al. Vaccine. 2025 Jan 1;43(Pt 1):126527. doi: 10.1016/j.vaccine.2024.126527. Epub 2024 Nov 14. Vaccine. 2025. PMID: 39547018 Free article.
METHODS: This prospective study was conducted at Keio University Hospital from 2002 to August 2023. We gave a live-attenuated vaccine to liver transplant (LT) recipients fulfilling criteria for live-attenuated vaccines, including criteria …
METHODS: This prospective study was conducted at Keio University Hospital from 2002 to August 2023. We gave a live-attenuated …
Generation of a Live Attenuated Influenza A Vaccine Using Chemical-Triggered Intein.
Chen J, Wang J, Zhu H, Zhang Y, Sun J, Wang W, Wei C, Zhong H, Dong M. Chen J, et al. ACS Synth Biol. 2023 Jun 16;12(6):1686-1695. doi: 10.1021/acssynbio.3c00020. Epub 2023 May 17. ACS Synth Biol. 2023. PMID: 37196336
Noticeable morbidity and mortality can be caused by influenza A virus in humans. Conventional live attenuated influenza vaccine (LAIV) is one of the main strategies to control the spread of influenza, but its protective efficacy is often limited by its subopt …
Noticeable morbidity and mortality can be caused by influenza A virus in humans. Conventional live attenuated influenza vac …
Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups.
Bonifacio JPPL, Williams N, Garnier L, Hugues S, Schmolke M, Mazel-Sanchez B. Bonifacio JPPL, et al. J Virol. 2022 Oct 26;96(20):e0087122. doi: 10.1128/jvi.00871-22. Epub 2022 Oct 3. J Virol. 2022. PMID: 36190240 Free PMC article.
Together with inactivated influenza vaccines (IIV), live attenuated influenza vaccines (LAIV) are an important tool to prevent influenza A virus (IAV) illnesses in patients. ...This study characterizes a safer LAIV candidate in two mouse models mimicki …
Together with inactivated influenza vaccines (IIV), live attenuated influenza vaccines (LAIV) are an important t …
Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges.
Tlaxca JL, Ellis S, Remmele RL Jr. Tlaxca JL, et al. Adv Drug Deliv Rev. 2015 Oct 1;93:56-78. doi: 10.1016/j.addr.2014.10.002. Epub 2014 Oct 12. Adv Drug Deliv Rev. 2015. PMID: 25312673 Review.
Many live attenuated vaccines are capable of eliciting both humoral and cell mediated immune responses if physicochemically stable in an appropriate delivery vehicle. ...Since most pathogens enter the body through the mucosal route, live-attenuated …
Many live attenuated vaccines are capable of eliciting both humoral and cell mediated immune responses if physicochemic …
PROTAC vaccine: A new way to live attenuated vaccines.
Li Z, Bai H, Xi X, Tian WX, Zhang JZH, Zhou D, Si L. Li Z, et al. Clin Transl Med. 2022 Oct;12(10):e1081. doi: 10.1002/ctm2.1081. Clin Transl Med. 2022. PMID: 36281705 Free PMC article. No abstract available.
25,772 results
You have reached the last available page of results. Please see the User Guide for more information.